Silvercrest Asset Management Group »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Silvercrest Asset Management Group

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A (KNSA) shares owned by Silvercrest Asset Management Group from 13F filings

Historical chart of Silvercrest Asset Management Group investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by Silvercrest Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by Silvercrest Asset Management Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.9M 126k 38.83

More positions owned by Silvercrest Asset Management Group

Microsoft Corporation (MSFT)
Broadcom (AVGO)
Apple (AAPL)
Alphabet Inc Class C cs (GOOG)
Ishares Tr Rus 1000 Grw Etf (IWF)
Abbott Laboratories (ABT)
Oracle Corporation (ORCL)
Cadence Bank (CADE)
Glacier Ban (GBCI)
Home Depot (HD)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Williams Companies (WMB)
Cisco Systems (CSCO)
Atmos Energy Corporation (ATO)
Alphabet Inc Class A cs (GOOGL)

View all positions for Silvercrest Asset Management Group

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Rubric Capital Management
Vanguard Group
Baker Bros. Advisors
Tang Capital Management
Fairmount Funds Management
Acadian Asset Management
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Morgan Stanley
Millennium Management
Pictet Asset Management Holding SA
FMR
Connor, Clark & Lunn Investment Management
Qube Research & Technologies
Parkman Healthcare Partners

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A